PUBLISHED CASE REPORTS AND SERIES
The first definite reference to an allergic reaction to nuts that I can find was by Blackfan in 19201. Blackfan described a 10-year-old child with eczema which was 'always intensified' by eggs, fish and nuts. ' The eating of any of them was followed almost immediately by a burning sensation in the throat, vomiting, diarrhoea, oedema of the lips and ears and urticaria. ' There was little scientific focus on peanut allergy until Bock described, in 1978, 14 children with challenge-proven reactions to peanut2. In 1981 Taylor published a paper reporting 10 peanut allergics who had safely consumed encapsulated peanut oil3. In 1984 Sampson and Albergo showed that there was 100% concordance between a positive food challenge with peanut skin prick test (SPT) and with the RAST test result4, i.e. all 8 children with a positive challenge were SPT and RAST positive to peanut, but the positive predictive value of SPT was only 44%. The negative predictive value of peanut SPT was higher than 95% and they concluded that 'the RAST should be restricted to the rare occasion when SPT is not possible '. In 1988 Yunginger first drew attention to food-related and anaphylactic deathss, 4 of 7 being due to peanut. Sampson (1992) later confirmed this finding with 3/6 fatal reactions in children and adolescents being due to peanut (Table 1) 6. An important feature of these 2 studies is the clear evidence that food prepared by other people outside the home (in cafes and restaurants) carries a great risk of peanut-related anaphylaxis, and that delay in the administration of adrenaline to subjects suffering severe reactions is associated with an adverse outcome.
In 1989 Bock and Atkins7 published the first data collected longitudinally and showed that peanut allergy usually persists into adult life, with one subject having a second double-blind placebo-controlled food challenge (DBPCFC) positive reaction 4 years after the first DBPCFC and 7 subjects remaining SPT positive several years after the first SPT. 16/32 subjects had suffered an accidental exposure in the year before review. One subject had a reaction to peanut 11 years after his last reaction. The same groups have shown that peanut accounts for a third of cases of food-related anaphylaxis presenting to emergency rooms8. The incidence of food-related anaphylaxis was calculated at 1/234 000 population per year. This rate is lower than that in Munich, Germany9, where food (type was not specified) caused 17/150 anaphylactic reactions in one calendar year in a population of 1 532 458. This gives an incidence of food-related anaphylaxis of 1/90 900 people per year. The severe nature of peanut allergy is also shown by the exclusion from challenge studies of 18/34 peanut allergics on the basis of a previous severe reaction, compared to the exclusion of 5/ 90 egg allergics and 3/32 milk allergics'0.
Attention has focused, more recently, on the cellular and immunological nature of peanut allergy and on the identification of the many potentially antigenic proteins that peanut has long been known to contain11. This line has significant consequences for families and care givers, including nurseries and schools32'33. A government policy of indemnity for schools is needed, because the real frequency of food allergy and its recognition by parents and doctors are likely to increase further in the next decade.
Many young children are reported to have had clear-cut reactions to peanuts in the first or second year of life but on first review by a doctor (often at the age of 3 or 4 years) there is no evidence of peanut allergy by either SPT or challenge. Were these children ever peanut allergic or has their peanut allergy resolved? It may be that the nature of peanut allergy is changing, due to the introduction of peanut into the diet of younger children. The rate of resolution of peanut allergy will never match that of either milk or egg allergy, but it is clear that skin prick testing and especially peanut challenge must become better established in the management of peanut-allergic children in Britain. Many British units never challenge with peanut and the use of SPT and RAST is variable. The results of longitudinal studies of young peanut allergics are awaited eagerly.
The identification of further peanut allergens and the development of recombinant allergens holds out hopes of desensitization therapy but the complexity of the protein profile of peanut and the variability of the patients' immune responses mean there is probably not a single antigen to which the majority of severely-affected subjects react. For any individual subject the risk of any individual protein may vary irrespective of its classification as a major or minor antigen. The characterization of T cell responses to individual proteins may help in the identification of functionally significant proteins. The investigation of the expression of HLA class II molecules by peanut allergics (WM Howell, Southampton, submitted) may lead to early identification of children at risk of peanut allergy.
Scientific and commercial groups are developing kits to detect peanut protein in finished foods at levels as low as 2 ppm. This extremely low dose may be below the threshold dose of peanut protein. In other food allergies, a minimum dose of 50-100mg dry protein is considered to be necessary to cause allergic reactions. We propose to undertake a double-blind food challenge study of peanut allergics to see if there is a lower protein dose threshold for peanut allergics.
CONCLUSIONS
There has been great progress in the study of peanut allergy in the last 5 years. Its prevalence may be increasing and the age at which it manifests (almost universally in broadly atopic children) appears to be decreasing. The care of peanut-allergic children in the community needs a coordinated, possibly nationally agreed approach, encompassing all forms of day care and schools and the adequate 43 training of staff and provision of adrenaline rescue treatment.
The underlying cellular mechanisms which mediate this most severe food allergy are being studied intensively in many laboratories. This research may lead to, among other new developments, accurate methods of detecting peanut in finished foods and to the identification of proteins that may form the basis of safe immunotherapy and which may even be outbred from peanuts.
It must be emphasized that, despite the surge of scientific and medical interest in the clinical and immunological features of peanut allergy, the cornerstone of the management of peanut allergy will always be peanut avoidance.
